Nuveen Asset Management’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | $402K | Buy |
316,614
+60,583
| +24% | +$76.9K | ﹤0.01% | 3052 |
|
2024
Q3 | $873K | Hold |
256,031
| – | – | ﹤0.01% | 2818 |
|
2024
Q2 | $1.2M | Sell |
256,031
-767,149
| -75% | -$3.58M | ﹤0.01% | 2644 |
|
2024
Q1 | $7.59M | Buy |
1,023,180
+377,377
| +58% | +$2.8M | ﹤0.01% | 1764 |
|
2023
Q4 | $6.54M | Sell |
645,803
-303,312
| -32% | -$3.07M | ﹤0.01% | 1823 |
|
2023
Q3 | $7.4M | Buy |
949,115
+263,458
| +38% | +$2.05M | ﹤0.01% | 1653 |
|
2023
Q2 | $5.64M | Buy |
685,657
+202,691
| +42% | +$1.67M | ﹤0.01% | 1841 |
|
2023
Q1 | $3.5M | Sell |
482,966
-207,325
| -30% | -$1.5M | ﹤0.01% | 2083 |
|
2022
Q4 | $6.12M | Buy |
690,291
+106,544
| +18% | +$945K | ﹤0.01% | 1802 |
|
2022
Q3 | $7.15M | Sell |
583,747
-2,153
| -0.4% | -$26.4K | ﹤0.01% | 1689 |
|
2022
Q2 | $6.93M | Sell |
585,900
-9,065
| -2% | -$107K | ﹤0.01% | 1744 |
|
2022
Q1 | $10.4M | Buy |
594,965
+36,522
| +7% | +$636K | ﹤0.01% | 1622 |
|
2021
Q4 | $16M | Sell |
558,443
-66,198
| -11% | -$1.9M | ﹤0.01% | 1369 |
|
2021
Q3 | $39.5M | Buy |
624,641
+24,149
| +4% | +$1.53M | 0.01% | 819 |
|
2021
Q2 | $34M | Buy |
600,492
+114,155
| +23% | +$6.47M | 0.01% | 981 |
|
2021
Q1 | $20.4M | Buy |
486,337
+15,104
| +3% | +$634K | 0.01% | 1308 |
|
2020
Q4 | $33M | Buy |
471,233
+1,833
| +0.4% | +$129K | 0.01% | 924 |
|
2020
Q3 | $13.2M | Buy |
469,400
+172,940
| +58% | +$4.85M | 0.01% | 1336 |
|
2020
Q2 | $8.77M | Sell |
296,460
-32,292
| -10% | -$955K | ﹤0.01% | 1566 |
|
2020
Q1 | $6.52M | Buy |
328,752
+73,787
| +29% | +$1.46M | ﹤0.01% | 1557 |
|
2019
Q4 | $7.55M | Buy |
254,965
+46,171
| +22% | +$1.37M | ﹤0.01% | 1753 |
|
2019
Q3 | $4.75M | Buy |
208,794
+25,097
| +14% | +$571K | ﹤0.01% | 1984 |
|
2019
Q2 | $4.55M | Buy |
+183,697
| New | +$4.55M | ﹤0.01% | 2045 |
|